Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan 13;6(1):e16146.
doi: 10.2196/16146.

Analysis of Diabetes Apps to Assess Privacy-Related Permissions: Systematic Search of Apps

Affiliations

Analysis of Diabetes Apps to Assess Privacy-Related Permissions: Systematic Search of Apps

José Javier Flors-Sidro et al. JMIR Diabetes. .

Abstract

Background: Mobile health has become a major vehicle of support for people living with diabetes. Accordingly, the availability of mobile apps for diabetes has been steadily increasing. Most of the previous reviews of diabetes apps have focused on the apps' features and their alignment with clinical guidelines. However, there is a lack of knowledge on the actual compliance of diabetes apps with privacy and data security guidelines.

Objective: The aim of this study was to assess the levels of privacy of mobile apps for diabetes to contribute to the raising of awareness of privacy issues for app users, developers, and governmental data protection regulators.

Methods: We developed a semiautomatic app search module capable of retrieving Android apps' privacy-related information, particularly the dangerous permissions required by apps, with the aim of analyzing privacy aspects related to diabetes apps. Following the research selection criteria, the original 882 apps were narrowed down to 497 apps that were included in the analysis.

Results: Approximately 60% of the analyzed diabetes apps requested potentially dangerous permissions, which pose a significant risk to users' data privacy. In addition, 28.4% (141/497) of the apps did not provide a website for their privacy policy. Moreover, it was found that 40.0% (199/497) of the apps contained advertising, and some apps that claimed not to contain advertisements actually did. Ninety-five percent of the apps were free, and those belonging to the "medical" and "health and fitness" categories were the most popular. However, app users do not always realize that the free apps' business model is largely based on advertising and, consequently, on sharing or selling their private data, either directly or indirectly, to unknown third parties.

Conclusions: The aforementioned findings confirm the necessity of educating patients and health care providers and raising their awareness regarding the privacy aspects of diabetes apps. Therefore, this research recommends properly and comprehensively training users, ensuring that governments and regulatory bodies enforce strict data protection laws, devising much tougher security policies and protocols in Android and in the Google Play Store, and implicating and supervising all stakeholders in the apps' development process.

Keywords: dangerous permissions; diabetes mellitus; mobile apps; privacy.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: LF-L is co-founder of Adhera Health Inc (USA), a digital health company that provides digital therapeutic solutions for people with chronic conditions

Figures

Figure 1
Figure 1
App selection process flowchart.
Figure 2
Figure 2
The top 14 dangerous permissions by app category (lifestyle, medical, education, and health and fitness) and type of privacy-related permission requested, as well as whether they included advertising (“True”) or not (“False”).

Similar articles

Cited by

References

    1. World Health Organization. Geneva: WHO Library; 2016. Global report on diabetes; pp. 1–88.
    1. Forbes J, Fotheringham A. Vascular complications in diabetes: old messages, new thoughts. Diabetologia. 2017 Nov;60(11):2129–2138. doi: 10.1007/s00125-017-4360-x. - DOI - PubMed
    1. Bourne RRA, Stevens GA, White RA, Smith JL, Flaxman SR, Price H, Jonas JB, Keeffe J, Leasher J, Naidoo K, Pesudovs K, Resnikoff S, Taylor HR. Causes of vision loss worldwide, 1990–2010: a systematic analysis. The Lancet Global Health. 2013 Dec;1(6):e339–e349. doi: 10.1016/S2214-109X(13)70113-X. - DOI - PubMed
    1. Hanyu H. Diabetes-Related Dementia. Adv Exp Med Biol. 2019;1128:147–160. doi: 10.1007/978-981-13-3540-2_8. - DOI - PubMed
    1. Klonoff DC. The current status of mHealth for diabetes: will it be the next big thing? J Diabetes Sci Technol. 2013 May 01;7(3):749–58. doi: 10.1177/193229681300700321. http://europepmc.org/abstract/MED/23759409 - DOI - PMC - PubMed

LinkOut - more resources